An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis
Nature Communications
2025
16
1
Multi‐Targeting Macrocyclic Peptides as Nanomolar Inhibitors of Self‐ and Cross‐Seeded Amyloid Self‐Assembly of α‐Synuclein
Angewandte Chemie International Edition
2025
64
14
Modulation of Alzheimer’s Disease Aβ40 Fibril Polymorphism by the Small Heat Shock Protein αB-Crystallin
Journal of the American Chemical Society
2024
146
28
19077-19087
Macrophage migration inhibitory factor (MIF) and its homolog D-dopachrome tautomerase (D-DT) are significant promotors of UVB- but not chemically induced non-melanoma skin cancer
Scientific Reports
2023
13
1
Pathways linking aging and atheroprotection in
Mif
‐deficient atherosclerotic mice
The FASEB Journal
2023
37
3
Lasso-grafted designer cytokines
Nature Biomedical Engineering
2022
Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation
Cellular and Molecular Life Sciences
2022
79
10
Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly
Nature Communications
2022
13
1
Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting
Nature Communications
2020
11
1
A MIF‐derived cyclopeptide that inhibits MIF binding and atherogenic signaling via the chemokine receptor CXCR2
ChemBioChem
2020